As discussed in a prior Goodwin Alert, the US Food and Drug Administration (FDA) recently released Draft Guidance for designating a platform technology for drug development pursuant to ยง 560k of the Federal Food, Drug, and...more
8/14/2024
/ Biologics ,
Coronavirus/COVID-19 ,
Draft Guidance ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Manufacturers ,
Patent Term Extensions ,
Patent Terms ,
Patents ,
Pharmaceutical Industry ,
Prescription Drugs